Scholarly Works - Conferences
Conference
Clin Transplant
·
August 2022
BACKGROUND: Treatment options for antibody-mediated rejection (AMR) are limited. Recent studies have shown that inhibition of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling can reduce inflammation and slow AMR progression. METHODS: We report ...
Full text
Link to item
Cite
Conference
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
·
October 2021
Link to item
Cite
Conference
AMERICAN JOURNAL OF TRANSPLANTATION
·
April 1, 2019
Link to item
Cite
Conference
AMERICAN JOURNAL OF TRANSPLANTATION
·
April 1, 2019
Link to item
Cite
Conference
AMERICAN JOURNAL OF TRANSPLANTATION
·
April 1, 2019
Link to item
Cite
Conference
AMERICAN JOURNAL OF TRANSPLANTATION
·
April 1, 2019
Link to item
Cite